​

Funding Round

Series C - Carlsmed

Series C - Carlsmed

Investment Firm

Overview

The company manufactures and sells the aprevo™ digital-to-device 3-D printed implant system for lumbar spine surgery.

Announced Date

Mar 18, 2024

Funding Type

Series C

Highlights

Location

United States, North America

Social

Investor Lead

U.S. Venture Partners

U.S. Venture Partners

U.S. Venture Partners is a early_stage_venture and late_stage_venture and venture firm.

B Capital

B Capital

B Capital is a early_stage_venture and grant and late_stage_venture and venture firm.

Participant Investors

2

Investor Name
Participant InvestorB Capital
Participant InvestorU.S. Venture Partners

Round Details and Background

Carlsmed raised $52500000 on 2024-03-18 in Series C

The company manufactures and sells the aprevo™ digital-to-device 3-D printed implant system for lumbar spine surgery.

Company Funding History

7

Announcment DateTransaction NameNumber Of InvestorsLead InvestorMoney Raised
Dec 16, 2020
Series A - Carlsmed
4-10.0M
Apr 19, 2022
Series B - Carlsmed
5-30.0M
Nov 04, 2019
Pre Seed Round - Carlsmed
1-undefined
Mar 18, 2024
Series C - Carlsmed
2-52.5M

Recent Activity

There is no recent news or activity for this profile.